TBXA2R–ACSL1 axis found to amplify RANKL-driven osteoclast differentiation in rheumatoid arthritis
Start here
On October 15, 2026, a team from the Second Affiliated Hospital of Guangzhou University of Chinese Medicine published a study in Nature Communications identifying the TBXA2R–ACSL1 axis as a contributor to bone destruction in rheumatoid arthritis. Using single-cell sequencing, the researchers showed that this axis cooperates with RANKL to amplify osteoclast differentiation, the process that drives bone erosion in the disease. The finding points to TBXA2R and ACSL1 as potential therapeutic targets beyond the established RANKL pathway. Questions that remain open include how the axis behaves in patients versus experimental models and whether targeting it can translate into a clinical approach.
Written by a model from the reports · updated 2 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- mp.weixin.qq.comSingle-cell sequencing reveals TBXA2R–ACSL1 axis amplifies RANKL-driven osteoclast differentiation in rheumatoid arthritis
On October 15, 2026, a team from the Second Affiliated Hospital of Guangzhou University of Chinese Medicine published a study in Nature Communications showing that the TBXA2R–ACSL1 axis works with RANKL to amplify osteoclast differentiation in rheumatoid arthritis.
Heat trend for this story
Heat now 7·Peak in the comparable set 10 (Oct 28 09:00)·Change over 24h in the comparable set –·Participants now 1
Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.